See more : Franco-Nevada Corporation (0QYZ.L) Income Statement Analysis – Financial Results
Complete financial analysis of DENTSPLY SIRONA Inc. (XRAY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DENTSPLY SIRONA Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- GateKeeper USA, Inc. (GTKP) Income Statement Analysis – Financial Results
- Valneva SE (INRLF) Income Statement Analysis – Financial Results
- windeln.de SE (WDL.DE) Income Statement Analysis – Financial Results
- Xuzhou Handler Special Vehicle Co., Ltd (300201.SZ) Income Statement Analysis – Financial Results
- TMT (INDIA) LTD. (TMTIND-B1.BO) Income Statement Analysis – Financial Results
DENTSPLY SIRONA Inc. (XRAY)
About DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.97B | 3.92B | 4.25B | 3.34B | 4.03B | 3.99B | 3.99B | 3.75B | 2.67B | 2.92B | 2.95B | 2.93B | 2.54B | 2.22B | 2.16B | 2.19B | 2.01B | 1.81B | 1.72B | 1.69B | 1.57B | 1.51B | 1.13B | 889.80M | 830.90M | 795.10M | 720.80M | 656.60M | 572.00M | 524.80M | 552.60M | 84.60M | 54.50M | 29.40M | 18.60M | 16.20M | 12.70M | 10.30M |
| Cost of Revenue | 1.88B | 1.80B | 1.89B | 1.69B | 1.86B | 1.92B | 1.80B | 1.74B | 1.16B | 1.32B | 1.37B | 1.37B | 1.26B | 1.09B | 1.05B | 1.04B | 969.05M | 881.49M | 846.12M | 847.71M | 797.72M | 780.84M | 559.42M | 384.84M | 359.30M | 341.20M | 319.60M | 303.80M | 269.70M | 247.00M | 274.00M | 52.30M | 33.70M | 18.00M | 11.50M | 9.90M | 8.00M | 7.00M |
| Gross Profit | 2.09B | 2.13B | 2.36B | 1.66B | 2.17B | 2.07B | 2.19B | 2.00B | 1.52B | 1.60B | 1.58B | 1.56B | 1.27B | 1.13B | 1.11B | 1.15B | 1.04B | 929.01M | 869.02M | 846.52M | 773.20M | 732.90M | 569.67M | 504.95M | 471.60M | 453.90M | 401.20M | 352.80M | 302.30M | 277.80M | 278.60M | 32.30M | 20.80M | 11.40M | 7.10M | 6.30M | 4.70M | 3.30M |
| Gross Profit Ratio | 52.61% | 54.23% | 55.54% | 49.58% | 53.74% | 51.87% | 54.80% | 53.42% | 56.73% | 54.74% | 53.46% | 53.15% | 50.18% | 50.88% | 51.45% | 52.51% | 51.78% | 51.31% | 50.67% | 49.96% | 49.22% | 48.42% | 50.45% | 56.75% | 56.76% | 57.09% | 55.66% | 53.73% | 52.85% | 52.93% | 50.42% | 38.18% | 38.17% | 38.78% | 38.17% | 38.89% | 37.01% | 32.04% |
| Research & Development | 184.00M | 174.00M | 171.00M | 115.00M | 131.30M | 160.50M | 151.70M | 128.50M | 74.90M | 80.80M | 85.10M | 85.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.62B | 1.60B | 1.55B | 0.00 | 0.00 | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 675.37M | 606.41M | 563.34M | 544.26M | 501.52M | 479.13M | 386.24M | 299.73M | 282.40M | 275.10M | 236.30M | 205.20M | 180.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | -7.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.62B | 1.59B | 1.55B | 1.44B | 1.72B | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 675.37M | 606.41M | 563.34M | 544.26M | 501.52M | 479.13M | 386.24M | 299.73M | 282.40M | 275.10M | 236.30M | 205.20M | 180.10M | 160.30M | 180.00M | 16.70M | 10.50M | 5.50M | 3.90M | 3.40M | 2.90M | 2.30M |
| Other Expenses | 374.00M | 1.29B | 18.00M | 271.00M | 115.00M | 1.34B | 2.07B | 44.10M | 81.20M | 11.10M | 13.40M | -490.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.43M | 0.00 | 0.00 | 0.00 | 0.00 | 5.07M | 41.36M | 39.60M | 37.50M | 32.40M | 28.10M | 21.50M | 20.00M | 19.80M | 4.20M | 3.00M | 2.40M | 1.20M | 500.00K | 500.00K | 400.00K |
| Operating Expenses | 2.18B | 1.76B | 1.72B | 1.44B | 1.72B | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 680.54M | 602.98M | 563.34M | 544.26M | 501.52M | 479.13M | 391.31M | 341.09M | 322.00M | 312.60M | 268.70M | 233.30M | 201.60M | 180.30M | 199.80M | 19.70M | 12.90M | 6.70M | 4.40M | 3.90M | 3.30M | 2.70M |
| Cost & Expenses | 4.05B | 3.56B | 3.61B | 3.12B | 3.59B | 3.64B | 3.48B | 3.27B | 2.23B | 2.47B | 2.52B | 2.52B | 2.20B | 1.83B | 1.77B | 1.78B | 1.65B | 1.48B | 1.41B | 1.39B | 1.30B | 1.26B | 950.73M | 725.94M | 681.30M | 653.80M | 588.30M | 537.10M | 471.30M | 427.30M | 473.80M | 72.00M | 46.60M | 24.70M | 15.90M | 13.80M | 11.30M | 9.70M |
| Interest Income | 0.00 | 60.00M | 55.00M | 1.00M | 2.40M | 2.10M | 2.40M | 2.00M | 2.20M | 5.59M | 8.12M | 8.76M | 9.46M | 4.25M | 5.03M | 17.09M | 26.43M | 12.48M | 9.01M | 5.47M | 1.87M | 0.00 | 0.00 | 862.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 81.00M | 60.00M | 55.00M | 48.00M | 29.40M | 37.30M | 38.30M | 35.90M | 55.90M | 46.91M | 49.63M | 56.85M | 44.62M | 25.09M | 17.83M | 32.53M | 11.98M | 10.80M | 17.77M | 25.10M | 26.08M | 38.18M | 0.00 | 10.15M | 8.50M | 157.10M | 8.10M | 6.00M | 12.20M | 0.00 | 39.20M | 3.80M | 2.80M | 800.00K | 0.00 | 200.00K | 400.00K | 400.00K |
| Depreciation & Amortization | 343.00M | 328.00M | 346.00M | 334.00M | 322.80M | 330.80M | 316.40M | 271.70M | 122.90M | 129.08M | 127.90M | 129.20M | 85.04M | 66.34M | 65.18M | 56.93M | 50.29M | 47.43M | 50.56M | 49.30M | 45.66M | 43.86M | 54.33M | 41.36M | 39.60M | 37.50M | 32.40M | 28.10M | 21.50M | 20.00M | 19.80M | 3.00M | 2.40M | 1.20M | 500.00K | 500.00K | 400.00K | 400.00K |
| EBITDA | 232.00M | -677.00M | 972.00M | 336.00M | 706.60M | -585.30M | -1.25B | 770.50M | 579.30M | 575.25M | 544.88M | 513.34M | 378.71M | 440.00M | 437.28M | 444.33M | 432.26M | 373.21M | 139.00M | 348.77M | 317.34M | 297.63M | 232.70M | 205.22M | 189.20M | 178.70M | 164.90M | 147.60M | 122.20M | 117.50M | 98.60M | 31.60M | 15.60M | 10.30M | 5.90M | 3.20M | 2.90M | 1.80M |
| EBITDA Ratio | 5.85% | 16.17% | 23.57% | 23.64% | 20.97% | 49.83% | 65.43% | 20.63% | 18.87% | 16.01% | 15.11% | 14.80% | 13.26% | 18.11% | 17.97% | 22.19% | 20.92% | 21.14% | 33.94% | 21.25% | 19.96% | 20.02% | 18.64% | 23.38% | 22.41% | 31.40% | 22.56% | 22.08% | 21.64% | 21.95% | 18.24% | 18.79% | 18.72% | 20.07% | 16.67% | 17.90% | 14.17% | 9.71% |
| Operating Income | -85.00M | 306.00M | 622.00M | 456.00M | 522.30M | -958.10M | -1.59B | 454.70M | 375.20M | 445.60M | 419.17M | 381.94M | 300.73M | 380.27M | 381.19M | 380.42M | 354.89M | 314.79M | 72.92M | 295.13M | 267.98M | 256.50M | 178.36M | 163.86M | 149.60M | 141.30M | 132.50M | 119.50M | 100.70M | 97.50M | 78.80M | 12.60M | 7.90M | 4.70M | 2.70M | 2.40M | 1.40M | 600.00K |
| Operating Income Ratio | -2.14% | 7.80% | 14.63% | 13.64% | 12.96% | -24.03% | -39.70% | 12.14% | 14.03% | 15.25% | 14.21% | 13.04% | 11.85% | 17.12% | 17.65% | 17.34% | 17.66% | 17.39% | 4.25% | 17.42% | 17.06% | 16.94% | 15.80% | 18.42% | 18.00% | 17.77% | 18.38% | 18.20% | 17.60% | 18.58% | 14.26% | 14.89% | 14.50% | 15.99% | 14.52% | 14.81% | 11.02% | 5.83% |
| Total Other Income/Expenses | -90.00M | -118.00M | -63.00M | -57.00M | -7.60M | -400.00K | -41.20M | -13.80M | -45.50M | -41.23M | -49.87M | -51.26M | -44.62M | -22.62M | -17.83M | -24.95M | 3.24M | 43.00K | -234.64M | -20.98M | -16.79M | -35.52M | 6.76M | -12.06M | -11.50M | -86.10M | -10.40M | -8.60M | -10.60M | -5.90M | -23.00M | -2.30M | -3.50M | -2.90M | -800.00K | 300.00K | -200.00K | -300.00K |
| Income Before Tax | -175.00M | -1.06B | 559.00M | -60.00M | 345.40M | -958.40M | -1.63B | 440.90M | 329.70M | 404.37M | 369.34M | 330.68M | 256.11M | 357.66M | 363.36M | 355.47M | 358.14M | 314.84M | 71.04M | 274.16M | 251.20M | 220.99M | 185.13M | 151.80M | 138.10M | 55.10M | 122.10M | 110.90M | 90.10M | 91.60M | 55.80M | 9.10M | 5.00M | 3.90M | 2.70M | 2.20M | 1.10M | 0.00 |
| Income Before Tax Ratio | -4.41% | -26.90% | 13.15% | -1.80% | 8.57% | -24.04% | -40.73% | 11.77% | 12.33% | 13.84% | 12.52% | 11.29% | 10.09% | 16.10% | 16.82% | 16.20% | 17.82% | 17.39% | 4.14% | 16.18% | 15.99% | 14.60% | 16.40% | 17.06% | 16.62% | 6.93% | 16.94% | 16.89% | 15.75% | 17.45% | 10.10% | 10.76% | 9.17% | 13.27% | 14.52% | 13.58% | 8.66% | 0.00% |
| Income Tax Expense | -43.00M | -105.00M | 138.00M | 23.00M | 82.30M | 52.50M | -53.20M | 9.50M | 77.00M | 81.12M | 52.15M | 8.92M | -11.02M | 89.23M | 88.94M | 71.60M | 98.48M | 91.12M | 25.63M | 63.87M | 81.34M | 73.03M | 63.63M | 50.78M | 48.20M | 20.30M | 47.50M | 43.70M | 36.10M | 37.50M | 27.70M | 3.80M | 2.10M | 1.50M | 1.00M | 900.00K | 300.00K | 500.00K |
| Net Income | -132.00M | -950.00M | 411.00M | -83.00M | 262.90M | -1.01B | -1.57B | 429.90M | 251.20M | 322.85M | 313.19M | 314.21M | 244.52M | 265.71M | 274.26M | 283.87M | 259.65M | 223.72M | 45.41M | 253.17M | 174.18M | 147.95M | 121.50M | 101.02M | 89.90M | 34.80M | 74.60M | 67.20M | 54.00M | 62.00M | 14.10M | 5.30M | 2.90M | 2.40M | 1.70M | 1.30M | 800.00K | 100.00K |
| Net Income Ratio | -3.33% | -24.22% | 9.67% | -2.48% | 6.52% | -25.36% | -39.39% | 11.48% | 9.39% | 11.05% | 10.61% | 10.73% | 9.64% | 11.96% | 12.70% | 12.94% | 12.92% | 12.36% | 2.65% | 14.94% | 11.09% | 9.77% | 10.76% | 11.35% | 10.82% | 4.38% | 10.35% | 10.23% | 9.44% | 11.81% | 2.55% | 6.26% | 5.32% | 8.16% | 9.14% | 8.02% | 6.30% | 0.97% |
| EPS | -0.62 | -4.41 | 1.88 | -0.38 | 1.18 | -4.51 | -6.86 | 1.97 | 1.79 | 2.28 | 2.20 | 2.22 | 1.73 | 1.85 | 1.85 | 1.90 | 1.71 | 1.44 | 0.29 | 1.58 | 1.11 | 0.95 | 0.78 | 0.65 | 0.57 | 0.22 | 0.46 | 0.42 | 0.33 | 0.37 | 0.09 | 0.10 | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.00 |
| EPS Diluted | -0.62 | -4.41 | 1.87 | -0.38 | 1.17 | -4.51 | -6.86 | 1.94 | 1.76 | 2.24 | 2.16 | 2.18 | 1.70 | 1.82 | 1.83 | 1.87 | 1.68 | 1.41 | 0.28 | 1.55 | 1.09 | 0.93 | 0.77 | 0.65 | 0.56 | 0.22 | 0.46 | 0.42 | 0.33 | 0.37 | 0.09 | 0.10 | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.00 |
| Weighted Avg Shares Out | 212.00M | 215.50M | 218.40M | 219.20M | 223.10M | 224.17M | 229.29M | 218.00M | 140.00M | 141.70M | 142.70M | 141.85M | 141.39M | 143.98M | 148.32M | 149.07M | 151.71M | 155.23M | 159.19M | 160.77M | 157.65M | 156.36M | 155.34M | 155.57M | 158.26M | 159.99M | 161.81M | 161.52M | 162.07M | 165.99M | 151.00M | 52.97M | 43.48M | 34.27M | 33.98M | 29.99M | 34.27M | 29.99M |
| Weighted Avg Shares Out (Dil) | 212.00M | 215.50M | 220.20M | 219.20M | 224.40M | 224.30M | 229.40M | 221.60M | 142.50M | 144.20M | 145.00M | 143.95M | 143.55M | 145.99M | 150.10M | 151.68M | 154.72M | 158.27M | 162.02M | 164.03M | 161.29M | 159.99M | 157.95M | 157.12M | 158.73M | 160.79M | 162.69M | 161.52M | 162.19M | 165.99M | 156.59M | 52.97M | 43.48M | 34.27M | 33.98M | 29.99M | 34.27M | 29.99M |
SHAREHOLDER DEADLINE NOTICE: Scott+Scott Attorneys at Law LLP Notifies Investors that a Securities Class Action Has Been Filed Against Dentsply Sirona, Inc. (NASDAQ: XRAY)
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, notifies investors that the deadline to move for lead plaintiff in a securities class action lawsuit against Dentsply Sirona, Inc. (NASDAQ: XRAY) (“Dentsply” or...
XRAY Investors Have Opportunity to Lead DENTSPLY SIRONA Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--XRAY Investors Have Opportunity to Lead DENTSPLY SIRONA Inc. Securities Fraud Lawsuit with the Schall Law Firm.
XRAY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Dentsply Sirona Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)---- $XRAY #DentsplySirona--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY) and certain of its officers....
Dentsply Sirona Inc. Investor Alert: Robbins LLP Reminds XRAY Stockholders of the Pending Class Action
SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased Dentsply Sirona Inc. (NASDAQ: XRAY) common stock between December 1, 2022 and November 6,...
ROSEN, A LEADING LAW FIRM, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XRAY
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between...
DENTSPLY SIRONA INC. (NASDAQ: XRAY) INVESTOR ALERT: Investors With Large Losses in DENTSPLY SIRONA Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of DENTSPLY SIRONA Inc. (“Dentsply”...
XRAY INVESTOR REPORT: BFA Law Alerts Dentsply Sirona Inc. Investors that a Class Action Lawsuit was Filed Against the Company for Fraud and Urges You to Contact the Firm (NASDAQ:XRAY)
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Dentsply Sirona Inc. (NASDAQ: XRAY) and certain of the company's senior executives for potential violations...
XRAY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Dentsply Sirona Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK , Dec. 1, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ: XRAY)...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DENTSPLY SIRONA Inc. - XRAY
NEW YORK, NY / ACCESSWIRE / December 1, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. ("Dentsply" or the "Company") (NASDAQ:XRAY). Such investors are advised to contact Danielle Peyton at [email protected]...
XRAY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Dentsply Sirona Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / December 1, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY)...
Source: https://incomestatements.info
Category: Stock Reports